Doses of antiplatelet co-therapies | Download Table
Antiplatelet therapy for STEMI - ppt download
ESC Guidelines on oral P2Y12 antiplatelet therapy in ACS. | Download Table
Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention | Circulation
Effect on Platelet Reactivity From a Prasugrel Loading Dose After a Clopidogrel Loading Dose Compared With a Prasugrel Loading Dose Alone | Circulation: Cardiovascular Interventions
DAY 3 - Acute Coronary Syndromes — The Intern at Work
Effectiveness of reloading to overcome clopidogrel nonresponsiveness in patients with acute myocardial infarction. | Semantic Scholar
Role of Clopidogrel Loading Dose in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Angioplasty
Antiplatelet and anticoagulation regimen in patients with mechanical valve undergoing PCI – State-of-the-art review - International Journal of Cardiology
2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy - Canadian Journal of Cardiology
Role of Clopidogrel Loading Dose in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Angioplasty: Results From the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial ...
Risk stratification and medical management of NSTE-ACS (UA/NSTEMI ) - ppt video online download
Antiplatelet therapy in coronary artery disease
Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes | NEJM
Antithrombotic strategies in elderly patients with acute coronary syndrome - ScienceDirect
Randomized Trial of High Loading Dose of Clopidogrel for Reduction of Periprocedural Myocardial Infarction in Patients Undergoing Coronary Intervention | Circulation
Overview of Antiplatelet Therapy for Myocardial Infarction | Thoracic Key
Effects of Crushed Ticagrelor Versus Eptifibatide Bolus Plus Clopidogrel in Troponin‐Negative Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Randomized Clinical Trial | Journal of the American Heart Association
PDF) Is There Safety in the Use of Clopidogrel Loading Dose in Patients Over 75 Years of Age with Acute Coronary Syndrome?
Treatment of NSTEMI (Non-ST Elevation Myocardial Infarction) | SpringerLink
Standard versus high loading doses of clopidogrel in Asian ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: Insights from the Korea Acute Myocardial Infarction Registry - ScienceDirect
ST-Segment Elevation Myocardial Infarction:What Role for Anticoagulants and Antiplatelet Agents? | Consultant360
PLATO – TIMI STUDY GROUP
Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial - The Lancet
Pharmacodynamic study of prasugrel or clopidogrel in non-ST-elevation acute coronary syndrome with CYP2C19 genetic variants undergoing percutaneous coronary intervention (PRAISE-GENE trial) - International Journal of Cardiology
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial - The Lancet
2020 APSC Recommendations on use of P2Y12 inhibitors in Asia